Phase 2 biotech developing an implantable drug-device for chronic rhinosinusitis.
Industry: Health Care
First Day Return: +16.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/06/2020 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 3.5 |
Deal Size ($mm) | $56 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/30/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $56 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Watertown, MA, United States |
Founded | 2005 |
Employees at IPO | 38 |
Website www.lyratherapeutics.com |